People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arcellx, Inc. | — | Biotechnology | Series D+ | $272.8M | $1.8B | 2021 |
| EvolveImmune Therapeutics Holding Company, LLC | — | Biotechnology | Series B | $85.8M | $124.8M | 2023 |
| Carbon Biosciences, Inc. | — | Biotech / Pharma | Series B | $38.0M | $743.9M | 2022 |
| Trefoil Therapeutics, Inc. | — | Biotechnology | Series A | $33.3M | $16.2M | 2019 |
Derek Yoon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Derek Yoon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hugo Beekman | 2 | 2 |
| Ali Behbahani | 1 | 17 |
| Stephen Bloch | 1 | 15 |
| David Steinberg | 1 | 14 |
| Tiba Aynechi | 1 | 9 |
| Geeta Vemuri | 1 | 7 |
| Christy Shaffer | 1 | 6 |
| Lewis T. Williams | 1 | 5 |
| Chen Schor | 1 | 4 |
| Jill Carroll | 1 | 4 |
| Stella Robertson | 1 | 4 |
| Ian Taylor | 1 | 3 |
| David Lubner | 1 | 3 |
| John Fucci | 1 | 3 |
| Jonathan Mow | 1 | 3 |
| Roger Sawhney | 1 | 2 |
| Kavita Patel | 1 | 2 |
| Lance Thibault | 1 | 2 |
| Robert Hadfield | 1 | 2 |
| Rami Elghandour | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.